ULTOMIRIS: payments to doctors
Payments that named ULTOMIRIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $17M
- Providers
- 29,460
- Transactions
- 105,626
- Average per transaction
- $161
The per-transaction average — $161 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 29,460 providers the average total is $577, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $17,004,872 | 100.0% |